What’s the current state and future prospects of medical device reimbursement in India? This Special Report critically examines the integration of Health Technology Assessments (HTA) into Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), India’s flagship social health insurance initiative aimed at delivering healthcare services to the nation's economically disadvantaged citizens.
Challenges to a robust reimbursement pathway
The report underscores several key challenges impeding the effectiveness of the existing reimbursement framework, including:
- Limited HTA capacities which hinder timely evaluations
- Inadequate partnerships with private stakeholders
- An absence of transparent mechanisms to track application and approval processes
- Disparities in healthcare access, with different parts of the country experiencing varying levels of service
Recommendations include:
- Enhanced reimbursement process. A proposed enhancement of the reimbursement process through a digitalized, user-friendly submission platform that promotes operational efficiency and reduces unnecessary delays.
- Discretionary Use of HTA. The report suggests a strategic and selective employment of HTA resources, focusing on areas with the highest impact on therapeutic outcomes and those shrouded in significant uncertainty.
- Communication and transparency. A vital reform is the call for established formal communication channels offering a two-way street for dialogue among payors, patients, providers, and manufacturers, thus fostering transparency and collaboration.
- Digital-native pathway. A push for a comprehensive digital infrastructure aims at streamlining applications and appeals, ultimately driving faster reimbursement decisions and better tracking of progress.
- Collaboration with experts. The report also benefits from contributors' insights, a mix of experts whose wealth of experience informs each recommendation, suggesting a holistic approach to the reimbursement challenge.
In sum, this Special Report articulates a detailed pathway towards more effective and inclusive medical device reimbursement strategies in India, aiming to accelerate access to essential healthcare while maintaining a cost-effective balance for the AB-PMJAY scheme. It paints a picture of robust partnership models between public and private entities, leveraging emerging technologies and evidence-driven methodologies to fulfill the promise of equitable healthcare delivery for all.
L.E.K. Consulting is a registered trademark of L.E.K. Consulting LLC. All other products and brands mentioned in this document are properties of their respective owners. © 2024 L.E.K. Consulting LLC
04162024160442